Searching for the next new blockbuster drug treatment Worcester Telegram Another biological drug called Daclizumab, under development with Weston-based Biogen Idec as a treatment for multiple sclerosis, is in the third and final phase of human studies. Scientists at AbbVie in Worcester are supporting that research, said ... |
